Dr. Ramesh K. Ramanathan is a board-certified medical oncologist, he joined Ironwood Physicians as Medical Director of Clinical Research in October 2023.
Dr. Ramanathan, previously lived in Phoenix prior joining the pharmaceutical Industry as Executive Director, Global Scientific Affairs, Merck Research Labs, Rahway, NJ, USA and Vice President, Zielbio, Charlottsville, VA.
Dr. Ramanathan served on the faculty of Mayo Clinic, Phoenix, AZ (2014-2018) and held appointments as Professor of Medicine at the Mayo Medical school with a joint appointment at the Translational Genomics Research Institute (TGEN), Phoenix, AZ. Prior to joining Mayo Clinic, he served as the medical director of the Virginia G. Piper Cancer Ctr- Clinical Trials Program, Scottsdale, AZ from 2007-2014 and at the University of Pittsburgh Cancer Institute from 1996-2007.
Dr. Ramanathan is a recognized expert for GI cancers and has research interests in new drug development. In the last 25 years, Dr. Ramanathan has been involved in the development of several new drugs (PARP, PI3K, hedgehog inhibitors, liposomal formulations etc), participated in numerous first in human agent studies and had a pivotal role in the development and approval of oxaliplatin for colon cancer and nab-paclitaxel for pancreatic cancer. He has published more than 200 papers in peer reviewed journals, as well as numerous book chapters. Dr Ramanathan has served on national professional committees and been an invited speaker at national and international meetings. Dr. Ramanathan is an Editorial Board member for Clinical Cancer Research, Cancer Chemotherapy and Pharmacology, Gastrointestinal Cancer Research and is an ad hoc reviewer for several high impact journals.
At Ironwood Physicians, Dr. Ramanathan will leverage his extensive experience from both academia and industry to expand the clinical trials program with innovative new agents. He also will have an active practice consulting on GI cancer patients. His other interests are cycling, tennis, chess and travelling.